Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Durham, North Carolina 27703


Purpose:

The purpose of this registry is to acquire safety data (including assessment of anti-rHuPH20 antibodies), regarding the course and outcome of pregnancy in women ever treated with HYQVIA. Development of the fetus/infant at birth and for the first 2 years will also be followed.


Criteria:

Inclusion Criteria: - For the expectant mother only: Participant became pregnant during or after treatment with HYQVIA - Participant/Participant's legally authorized representative is willing to sign an informed consent form (ICF) Exclusion Criteria: - There are no applicable Exclusion Criteria


NCT ID:

NCT02556775


Primary Contact:

Study Director
Shire Director
Shire


Backup Contact:

N/A


Location Contact:

Durham, North Carolina 27703
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.